These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9817534)

  • 1. The natural history of multiple sclerosis: update 1998.
    Weinshenker BG
    Semin Neurol; 1998; 18(3):301-7. PubMed ID: 9817534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of multiple sclerosis.
    Weinshenker BG
    Neurol Clin; 1995 Feb; 13(1):119-46. PubMed ID: 7739500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Course of illness and prognosis of multiple sclerosis. 1: The natural illness course].
    Flachenecker P; Hartung HP
    Nervenarzt; 1996 Jun; 67(6):435-43. PubMed ID: 8767197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K; Khader Y
    Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of the individual course of disease--steps in developing a decision support tool for Multiple Sclerosis.
    Daumer M; Neuhaus A; Lederer C; Scholz M; Wolinsky JS; Heiderhoff M;
    BMC Med Inform Decis Mak; 2007 May; 7():11. PubMed ID: 17488517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The natural history of multiple sclerosis].
    Confavreux C; Vukusic S
    Rev Prat; 2006 Jun; 56(12):1313-20. PubMed ID: 16948219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of multiple sclerosis: have available therapies impacted long-term prognosis?
    Trojano M; Paolicelli D; Tortorella C; Iaffaldano P; Lucchese G; Di Renzo V; D'Onghia M
    Neurol Clin; 2011 May; 29(2):309-21. PubMed ID: 21439443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability as an outcome in MS clinical trials.
    Ebers GC; Heigenhauser L; Daumer M; Lederer C; Noseworthy JH
    Neurology; 2008 Aug; 71(9):624-31. PubMed ID: 18480462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors].
    Flachenecker P; Hartung HP
    Nervenarzt; 1996 Jun; 67(6):444-51. PubMed ID: 8767198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of multiple sclerosis: long-term prognostic factors.
    Renoux C
    Neurol Clin; 2011 May; 29(2):293-308. PubMed ID: 21439442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of multiple sclerosis with childhood onset.
    Renoux C; Vukusic S; Confavreux C
    Clin Neurol Neurosurg; 2008 Nov; 110(9):897-904. PubMed ID: 18534742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically isolated syndromes: predicting and delaying multiple sclerosis.
    Thrower BW
    Neurology; 2007 Jun; 68(24 Suppl 4):S12-5. PubMed ID: 17562845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of multiple sclerosis in Australia.
    McLeod JG; Barnett MH; Macaskill P; Williams DB
    J Neurol Sci; 2007 May; 256(1-2):35-8. PubMed ID: 17368674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives in the natural history of multiple sclerosis.
    Tremlett H; Zhao Y; Rieckmann P; Hutchinson M
    Neurology; 2010 Jun; 74(24):2004-15. PubMed ID: 20548045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system atrophy and clinical status in multiple sclerosis.
    Zivadinov R; Bakshi R
    J Neuroimaging; 2004 Jul; 14(3 Suppl):27S-35S. PubMed ID: 15228757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New options for early treatment of multiple sclerosis.
    Tintoré M
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S9-S11. PubMed ID: 19200870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis.
    Gaudino EA; Chiaravalloti ND; DeLuca J; Diamond BJ
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):32-44. PubMed ID: 11234907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression in multiple sclerosis: further evidence of an age dependent process.
    Koch M; Mostert J; Heersema D; De Keyser J
    J Neurol Sci; 2007 Apr; 255(1-2):35-41. PubMed ID: 17331540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting and preventing the future: actively managing multiple sclerosis.
    Hutchinson M
    Pract Neurol; 2009 Jun; 9(3):133-43, discussion 144. PubMed ID: 19448055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.